01 6Pfizer Canada Inc.
01 22091562
02 22198599
03 22352392
01 6Eletriptan Hydrobromide
01 6Tablet
01 22011-10-08
02 22015-05-17
03 22019-11-01
Patent Expiration Date : 2019-11-01
Date Granted : 2006-01-24
Brand Name : RELPAX
Patent Number : 2352392
Filing Date : 1999-11-01
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-11-01
Date Granted : 2006-01-24
Patent Expiration Date : 2019-11-01
Date Granted : 2006-01-24
Brand Name : RELPAX
Patent Number : 2352392
Filing Date : 1999-11-01
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2019-11-01
Date Granted : 2006-01-24
Patent Expiration Date : 2011-10-08
Date Granted : 2001-03-27
Brand Name : RELPAX
Patent Number : 2091562
Filing Date : 1991-10-08
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-10-08
Date Granted : 2001-03-27
Patent Expiration Date : 2015-05-17
Date Granted : 2000-06-06
Brand Name : RELPAX
Patent Number : 2198599
Filing Date : 1995-05-17
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-05-17
Date Granted : 2000-06-06
Patent Expiration Date : 2011-10-08
Date Granted : 2001-03-27
Brand Name : RELPAX
Patent Number : 2091562
Filing Date : 1991-10-08
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-10-08
Date Granted : 2001-03-27
Patent Expiration Date : 2015-05-17
Date Granted : 2000-06-06
Brand Name : RELPAX
Patent Number : 2198599
Filing Date : 1995-05-17
Strength per Unit : 40 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2015-05-17
Date Granted : 2000-06-06
LOOKING FOR A SUPPLIER?
